Celularity (CELUW) Amortization - Intangibles (2020 - 2025)
Celularity (CELUW) reported Amortization - Intangibles of $368000.0 for Q1 2025, down 32.6% year-over-year from $546000.0 in Q1 2024, and down 2.13% quarter-over-quarter from $376000.0 in Q4 2024.
Celularity (CELUW) Amortization - Intangibles (2020 - 2025) Analysis & Trends
Celularity (CELUW) has 6 years of Amortization - Intangibles data on file, last reported at $368000.0 in Q1 2025.
- Amortization - Intangibles for Q1 2025 came in at $368000.0, down 32.6% year-over-year; the trailing twelve-month figure through Mar 2025 was $1.6 million (down 28.34% YoY), and the FY2025 annual result was $1.5 million, down 14.83% from the prior year.
- Amortization - Intangibles slipped to $368000.0 in Q1 2025 per CELUW's latest filing, from $376000.0 in the prior quarter.
- Over five years, Amortization - Intangibles peaked at $553000.0 in Q3 2021 and troughed at $368000.0 in Q1 2025.
- A 5-year average of $511705.9 and a median of $546000.0 in 2021 frame the typical range for Amortization - Intangibles.
- The sharpest annual moves came in 2024 and 2025: Amortization - Intangibles advanced 0.92% in 2024, then plunged 32.6% in 2025.
- A 5-year view of Amortization - Intangibles shows it stood at $552000.0 in 2021, then gained by 0.18% to $553000.0 in 2022, then changed by 0.0% to $553000.0 in 2023, then tumbled by 32.01% to $376000.0 in 2024, then declined by 2.13% to $368000.0 in 2025.
- Business Quant data shows CELUW's Amortization - Intangibles at $368000.0 in Q1 2025, $376000.0 in Q4 2024, and $375000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Celularity | - | - | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 368,000.00 |
| Dec 31, 2024 | 376,000.00 |
| Sep 30, 2024 | 375,000.00 |
| Jun 30, 2024 | 456,000.00 |
| Mar 31, 2024 | 546,000.00 |
| Dec 31, 2023 | 553,000.00 |
| Sep 30, 2023 | 553,000.00 |
| Jun 30, 2023 | 546,000.00 |
| Mar 31, 2023 | 541,000.00 |
| Dec 31, 2022 | 553,000.00 |
| Sep 30, 2022 | 553,000.00 |
| Jun 30, 2022 | 546,000.00 |
| Mar 31, 2022 | 541,000.00 |
| Dec 31, 2021 | 552,000.00 |
| Sep 30, 2021 | 553,000.00 |
| Jun 30, 2021 | 546,000.00 |
| Mar 31, 2021 | 541,000.00 |
| Dec 31, 2020 | 551,000.00 |
| Sep 30, 2020 | 783,000.00 |